These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4966138)

  • 21. [Considerations on the diagnostic control in the hemolytic disease of the newborn due to ABO incompatibility].
    Rondini G; Zaverio S
    Clin Pediatr (Bologna); 1967 Sep; 49(9):439-52. PubMed ID: 5608286
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cholinesterase activity of the blood serum in hemolytic disease of the newborn].
    Lopatina NI; Matrosova AV; Punchenok NA
    Vopr Okhr Materin Det; 1967 Jan; 12(1):35-40. PubMed ID: 5628729
    [No Abstract]   [Full Text] [Related]  

  • 23. [Serum acetylcholinesterase activity in newborn infants with hemolytic disease and metabolic hyperbilirubinemia].
    Willgerodt H; Theile H; Egerland A
    Padiatr Grenzgeb; 1971; 10(4):227-34. PubMed ID: 5169735
    [No Abstract]   [Full Text] [Related]  

  • 24. [Late anemia in hemolytic disease of the newborn].
    Molaro GL; Vazzoler G
    Minerva Pediatr; 1966 Nov; 18(35):2072-7. PubMed ID: 4969530
    [No Abstract]   [Full Text] [Related]  

  • 25. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 26. SEROLOGICAL ASPECT OF HEMOLYTIC DISEASE OF NEWBORN.
    ISLAMI ZS
    Va Med Mon (1918); 1963 Oct; 90():530. PubMed ID: 14069389
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of adenosintriphosphatase activity of erythrocytes in newborns with hemolytic disease.
    Ossipov AI
    Indian Pediatr; 1972 Jul; 9(7):408-10. PubMed ID: 4265408
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current status of the problem of child immunity. IV. Immunologic mechanisms of hemolytic disease of the newborn infant].
    Afonina LG
    Med Sestra; 1978 Aug; 37(8):6-10. PubMed ID: 100664
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rare case of a hemolytic newborn infant--disease from anti-e-antibodies].
    Rybcznski J; Skorczynski M; Skrzelewski A; Toll A; Polak S
    Bibl Haematol; 1965; 23():899-901. PubMed ID: 4956295
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complications arising in hemolytic disease of newborn].
    Maskiewicz W; Ornat K; Ziemniak J
    Pediatr Pol; 1977 Mar; 52(3):293-8. PubMed ID: 403504
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum complement in hemolytic disease of the newborn].
    Gravina E; Gravina-Sanvitale G
    Minerva Pediatr; 1971 Feb; 23(5):199-203. PubMed ID: 4995757
    [No Abstract]   [Full Text] [Related]  

  • 32. [Protective mechanisms in hemolytic disease of the newborn. (Rhesus system)].
    Gonzalez Ramos M
    Ginecol Obstet Mex; 1966; 21(123):469-75. PubMed ID: 4967226
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemolytic disease of the newborn].
    Nakayama K; Fujisawa S
    Rinsho Byori; 1967; ():Suppl 14:61-70. PubMed ID: 4969613
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro modifications of red cell acetylcholinesterase activity.
    Herz F; Kaplan E
    Br J Haematol; 1974 Feb; 26(2):165-78. PubMed ID: 4602904
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the lipid metabolism of fetal erythroblastosis Rh and ABO. Non-esterified plasma fatty acids and gas chromatographic fractionation of plasma and erythrocyte fatty acids].
    Salvioli GP; Ambrosioni G; Allocca G
    Haematologica; 1968; 53(7):534-55. PubMed ID: 4976852
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thin layer chromatography of the total lipids in hemolytic disease of the newborn (Rh and ABO). 1. Principal lipid fractions in the plasma and quantitative determination of lipemia].
    Salvioli GP; Allocca G; Ambrosioni G
    Clin Pediatr (Bologna); 1968 Oct; 50(10):645-53. PubMed ID: 4988028
    [No Abstract]   [Full Text] [Related]  

  • 39. [Erythrocyte sedimentation and clinical findings in newborn infants with hemolytic disease].
    Maszkiewicz W; Irzyńska D
    Pediatr Pol; 1977 May; 52(5):503-6. PubMed ID: 407544
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hematologic diagnosis of hemolytic disease of the newborn].
    Martín Villar J; Navarro Navarro JL
    Acta Obstet Ginecol Hisp Lusit; 1968; 16(4):285-93. PubMed ID: 4988904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.